2024 Conference Publication A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerationsAikebuse, Melanie, Gracen, Lucy, Sarraf, Babak, Mcphail, Steven, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
2024 Conference Publication qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopyKleiner, David E., Clouston, Andrew D., Goodman, Zachary, Guy, Cynthia D., Brunt, Elizabeth M., Lackner, Carolin, Tiniakos, Dina G., Wee, Aileen, Yeh, Matthew, Leow, Wei Qiang, Chng, Elaine, Ren, Yayun, Goh, George Boon Bee, Powell, Elizabeth E., Rinella, Mary E., Sanyal, Arun J, Neuschwander-Tetri, Brent A., Younossi, Zobair, Charlton, Michael, Ratziu, Vlad, Harrison, Stephen A., Tai, Dean and Anstee, Quentin M. (2024). qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy. EASL Congress 2024, Milan, Italy, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(24)01444-2 |
2023 Conference Publication Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort studyHong, Zhen Howe, Johnson, Stephanie, Ha, Tina, McIvor, Carolyn, Stuart, Katherine, Valery, Patricia, Powell, Elizabeth and Hayward, Kelly (2023). Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0168-8278(23)00794-8 |
2023 Conference Publication DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTERLankford, Allison, Gerding, James, Jones, Kevin, Cires-Drouet, Rafael, Tran, Quincy, Haase, Daniel, Nagarsheth, Khanjan, Naselsky, Warren, Jayanathan, Mark, Drummond, Rosa and Powell, Elizabeth (2023). DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2023 Conference Publication IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENTHaase, Daniel, Widjaja, Austin, Aquino, Alexa, Aligabi, Ayah, Bzhilyanskaya, Vera, Epstein, Jacob, Faisal, Manal, Kowansky, Taylor, Lin, Yiting, Okolo, Robinson, Plotnikova, Anya, Quackenbush, Jane, Sahadzic, Iana, Singh, Aditi, Tang, Kaitlyn, Yardi, Isha, Niles, Erin, Hart, Emily, Powell, Elizabeth and Tran, Quincy (2023). IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2023 Conference Publication PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORTRamadan, Leena, Shi, Tesia, Esposito, Emily, Powell, Elizabeth, Tran, Quincy, Motta, Melissa, Scalea, Thomas and Tabatabai, Ali (2023). PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2022 Conference Publication Non-alcoholic fatty liver disease and type 2 diabetes: low referral rate of patients at increased risk of progressive liver diseaseGracen, Lucy, Hayward, Kelly, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2022). Non-alcoholic fatty liver disease and type 2 diabetes: low referral rate of patients at increased risk of progressive liver disease. AMSTERDAM: ELSEVIER. |
2021 Conference Publication BACTERAEMIA, SEPSIS, AND ANTIBIOTIC RESISTANCE IN AUSTRALIAN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDYJohnson, Amy, Ratnasekera, Isanka, Irvine, Katharine, Henderson, Andrew, Powell, Elizabeth and Valery, Patricia (2021). BACTERAEMIA, SEPSIS, AND ANTIBIOTIC RESISTANCE IN AUSTRALIAN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDY. Annual Meeting of the British-Society-of-Gastroenterology (BSG), Electr Network, Nov 08-12, 2021. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/gutjnl-2021-BSG.235 |
2019 Conference Publication A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLDMcKillen, B., Elangovan, H., Horsfall, L., Patel, P., Hayward, K., Clouston, A., Radford-Smith, D., Valery, P., Britton, L., Brown, N., Bernard, A. and Powell, E. (2019). A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA Australia, 8–10 September 2019. Richmond, VIC Australia: Wiley-Blackwell. |
2019 Conference Publication Health-related quality of life in patients with cirrhosisAmarasena, S., Bernardes, C., Stuart, K., Gupta, R., Horsfall, L., Rahman, T., Clark, P., Skoien, R., Hartel, G., Hayward, K., Powell, E. and Valery, P. (2019). Health-related quality of life in patients with cirrhosis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Online, 21–30 November 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.15269 |
2019 Conference Publication Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 InflammationIyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J. and Fairlie, David P. (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. Experimental Biology Meeting (EB), Orlando Fl, Apr 06-09, 2019. HOBOKEN: WILEY. |
2018 Conference Publication Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scoresPatel, Preya, Cheng, Johnson Chieh-Yu, Banh, Xuan, Hossain, Fabrina, Horsfall, Leigh Ula, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine A., Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine, Clouston, Andrew D., Bernard, Anne and Powell, Elizabeth E. (2018). Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, San Francisco, CA United States, 9-13 November 2018. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1002/hep.30257 |
2017 Conference Publication Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?Patel, P. J., Smith, D. D., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N. N., Saad, N., Clouston, A. D., Irvine, K. M., Russell, A. W., Valery, P. C. and Powell, E. E. (2017). Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?. International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands, 19-23 April 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(17)31602-1 |
2017 Conference Publication Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetesPatel, P. J., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Saad, N., Clouston, A., Irvine, K. M., Russell, A., Valery, P. C. and Powell, E. E. (2017). Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes. Gastroenterological Society of Australia Australian Gastroenterology Week Precision Medicine in Gastroenterology, Gold Coast, QLD Australia, 20 - 22 August 2017. Richmond, VIC Australia: Wiley-Blackwell. |
2016 Conference Publication Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetesPatel, P. J., Stuart, K. A., Horsfall, L. U., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Clouston, A., Irvine, K. M., Russell, A. and Powell, E. E. (2016). Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, South Australia, Australia, 10–12 October, 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13520 |
2016 Conference Publication Medication adherence in outpatients with decompensated cirrhosisHayward, K. L., Cottrell, W. N., Karmakar, A., Patel, P. J., Horsfall, L. U., Martin, J. H., Irvine, K. M., Tallis, C. J., Wright, P. L., Stuart, K. A., Valery, P. C. and Powell, E. E. (2016). Medication adherence in outpatients with decompensated cirrhosis. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, SA Australia, 10–12 October 2016. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13520 |
2015 Conference Publication An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, AustraliaValery, P. C., Clark, P. J., Mcphail, S. M., Martin, J., Horsfall, L., Volk, M. L. and Powell, E. (2015). An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. HOBOKEN: WILEY-BLACKWELL. |
2015 Conference Publication Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activationIrvine, K. M., Clouston, A. D., Blumenthal, A. and Powell, E. E. (2015). Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD, Australia, 28 September - 2 October 2015. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.13087 |
2015 Conference Publication Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injuryIrvine, Katharine, Clouston, Andrew D., Blumenthal, Antje and Powell, Elizabeth E. (2015). Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury. 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, United States, Nov 13-17, 2015. Hoboken, United States: John Wiley & Sons. |
2015 Conference Publication Discrepancies in the use of medications in patients with cirrhosisHayward, K., Valery, P. C., Cottrell, N., Irvine, K., Horsfall, L., Ruffin, B., Tallis, C., Chachay, V., Martin, J. and Powell, E. (2015). Discrepancies in the use of medications in patients with cirrhosis. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD Australia, 28 September - 2 October 2015. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13093 |